Table 1 from CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)

Key Points

MAIN FINDING: This analysis provides insight into baseline characteristics of patients with primary retroperitoneal sarcoma.
KEY EVIDENCE: Data from both CINSARC and the EORTC-STBSG-62092 trial (STRASS) was utilized for comparison.
APPROACH: The study involved reviewing single-institution data alongside information from a multicenter clinical trial.
SIGNIFICANCE: Findings may help in tailoring treatment approaches for patients with primary retroperitoneal sarcoma.

We only have this paper's title and publication details.

Analysis combines data from CINSARC and STRASS trial, focusing on baseline characteristics of patient cohorts.

Baseline characteristics of the INT and STRASS cohorts.

No takes yet. Share an insight, caveat, or question.

Callegaro et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share